Literature DB >> 10037078

Normokalemic thyrotoxic periodic paralysis: a new therapeutic strategy.

O González-Treviño1, J Rosas-Guzmán.   

Abstract

An unusual presentation of periodic paralysis in a Mexican man with thyrotoxicosis is presented. The patient suffered paralysis of the lower extremities without apparent precipitating factors such as hypokalemia, exercise, carbohydrate or alcohol ingestion. Hyperthyroidism was managed first with a thyroid suppressant (methimazole) and propranolol. Prednisone was added after another episode of paralysis. Definitive treatment of hyperthyroidism was achieved with radioactive iodine, which subsequently required substitution therapy with thyroxine. A moderate dose of thyroxine (100 microg) caused muscular weakness. Treatment of thyrotoxicosis and flaccid paralysis as well as the effects of glucocorticoids on thyroid function are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037078     DOI: 10.1089/thy.1999.9.61

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  4 in total

1.  Thyrotoxic periodic paralysis in long standing graves' disease: an unusual presentation with normokalemia.

Authors:  Lakshmi Kannan; Young Nam Kim
Journal:  N Am J Med Sci       Date:  2015-03

2.  A 32-year-old Man with Normokalemic Thyrotoxic Periodic Paralysis.

Authors:  Neda Valizadeh; Sahar Zarrin
Journal:  Malays J Med Sci       Date:  2013-01

3.  Fatal thyrotoxic periodic paralysis with normokalemia.

Authors:  Nitin Satam; Vaishali More; Preeti Shanbag; Alka Kalgutkar
Journal:  Indian J Pediatr       Date:  2007-11       Impact factor: 1.967

Review 4.  Thyrotoxic periodic paralysis: an overview.

Authors:  Chang-Hsun Hsieh; Shi-Wen Kuo; Dee Pei; Yi-Jen Hung; Sandra Chyi-Fan; Ling-I Wu; Chih-Tsueng He; Tsao-Chin Yang; Wei-Cheng Lian; Lee Chien-Hsing
Journal:  Ann Saudi Med       Date:  2004 Nov-Dec       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.